Toffanin, Sara

Publishing since 2008 (Baby)

Has published 10 publications in 3 years

Number of publications published per year by Toffanin, Sara. (Source : PubMed)

Distribution of publications types for Toffanin, Sara. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Solé M, Thung S, Moyano S, Toffanin S, Mínguez B, Cabellos L, Peix J, Schwartz M, Mazzaferro V, Bruix J, Llovet JM. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J. Hepatol. 2010;52;4
Bhoori S, Toffanin S, Sposito C, Germini A, Pellegrinelli A, Lampis A, Mazzaferro V. Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle. J. Hepatol. 2010
Toffanin S, Villanueva A, Llovet JM. miRNA delivery: emerging therapy for hepatocellular carcinoma. Gastroenterology 2010;138;3
Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin. Liver Dis. 2010;30;1
Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, Savic R, Hoshida Y, Lim KH, Melgar-Lesmes P, Yea S, Peix J, Deniz K, Fiel MI, Thung S, Alsinet C, Tovar V, Mazzaferro V, Bruix J, Roayaie S, Schwartz M, Friedman SL, Llovet JM. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J. Hepatol. 2009;51;4
Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA, Lockhart VL, Shah SP, Tanwar PS, Mermel CH, Beroukhim R, Azam M, Teixeira J, Meyerson M, Hughes TP, Llovet JM, Radich J, Mullighan CG, Golub TR, Sorensen PH, Daley GQ. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009;41;7
Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008;135;6
Toffanin S, Daidone MG, Miodini P, De Cecco L, Gandellini P, Cappelletti V. Clusterin: a potential target for improving response to antiestrogens. Int. J. Oncol. 2008;33;4
Villanueva A, Toffanin S, Llovet JM. Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps. Curr Opin Oncol 2008;20;4
Cappelletti V, Gariboldi M, De Cecco L, Toffanin S, Reid JF, Lusa L, Bajetta E, Celio L, Greco M, Fabbri A, Pierotti MA, Daidone MG. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer. Endocr. Relat. Cancer 2008;15;2

[ See timeline ] [ See all publications ]

h=6

means that Toffanin, Sara has 6 papers cited a least 6 times - methodology

Key figures

10 pub in 3 years
3.3 publications/year
best year 2008 with 4 pub
h-index 6 with 10 pub
h-ratio : 60 %

See Timeline

Ranking

It's me !

Click here if you are
Toffanin, Sara.

Most frequent Journals

J. Hepatol. (3x)
Gastroenterology (2x)
Curr Opin Oncol (1x)
Semin. Liver Dis. (1x)
Int. J. Oncol. (1x)

Main affiliation

Mount Sinai Liver Cancer Program, Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA.

Latest co-workers

Alsinet C Bruix J Cabellos L Cappelletti V Chiang DY De Cecco L Fiel MI Friedman SL Hoshida Y Llovet JM Mazzaferro V Meyerson M Minguez B Newell P Peix J Roayaie S Schwartz M Thung S Tovar V Villanueva A

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.